抑郁及抗抑郁药氟西汀对骨结合影响的临床前体内实验研究
12周后结果显示,抑郁和氟西汀均独立降低骨密度和骨-种植体接触百分比,两者同时存在时损害加重。
要点
- 抑郁和氟西汀均独立负向影响骨密度与种植体骨结合。
- 抑郁与氟西汀同时存在时对骨结合损害加重。
- 机制可能与下丘脑-垂体-肾上腺轴失调及炎症相关。
核心结论
- 抑郁和氟西汀独立地对骨密度及种植体骨结合产生负面影响,两者并存时损害加剧。
- 其机制可能与下丘脑-垂体-肾上腺轴失调及体内炎症有关。
研究设计与样本
- 抑郁组和抑郁+氟西汀组接受抑郁造模,对照组和氟西汀组正常饲养;所有大鼠右侧胫骨植入钛种植体。
- 氟西汀组和抑郁+氟西汀组每日皮下注射氟西汀,对照组和抑郁组皮下注射生理盐水;采集血清用于ELISA,手术区域取材进行microCT和组织学观察。
主要发现
- 12周后,抑郁+氟西汀组骨密度低于对照组、抑郁组和氟西汀组。
- 抑郁组和氟西汀组骨密度均低于对照组。
- 抑郁+氟西汀组骨-种植体接触百分比(BIC%)低于对照组、抑郁组和氟西汀组。
- 抑郁组和氟西汀组BIC%均低于对照组。
临床怎么用
- 提示临床关注抑郁状态及氟西汀使用对种植体骨结合的潜在不利影响。
- 抑郁合并氟西汀治疗的患者种植风险可能更高,需加强术前评估与术后监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to explore the effect of depression and selective serotonin reuptake inhibitors on implant osseointegration and bone healing. METHODS: Forty-eight 6- to 8-week-old SPF Sprague-Dawley male rats were randomly divided into four groups: the Control group, the Fluoxetine group, the Depression group and the De&Flu group. The rats in the Depression group and the De&Flu group were subjected to a depression modelling process, and the rats in the Control group and the Fluoxetine group were raised normally. Then, a titanium implant was placed in the right tibia of each rat. In the Fluoxetine group and De&Flu group, fluoxetine was injected subcutaneously daily, while subcutaneously injecting physiological saline in the Control group and Depression group. Collecting serum from the rats used for ELISA. The surgical area was cut for microcomputed tomography and histology observation. RESULTS: After 12 weeks, bone mineral density was lower in the De&Flu group than in the Control group, Depression group and Fluoxetine group. Bone mineral density was also lower in the Depression group and the Fluoxetine group than in the Control group. The percentage of bone-implant contact (BIC%) in De&Flu rats was lower than in the Control, Depression and Fluoxetine groups. The BIC% in the Depression group and the Fluoxetine group was lower than in the Control group. CONCLUSIONS: Depression and fluoxetine negatively affect bone density and implant osseointegration independently, and this damaging effect is exacerbated when both factors are present. The mechanism may be related to the dysregulation of the hypothalamic-pituitary-adrenal axis and inflammation in the body.
引用
- Xiaowen Y, Zhu J, Gong M, et al. Effect of depression and the antidepressant fluoxetine on osseointegration-A pre-clinical in vivo experimental study. Clin Oral Implants Res. 2024. PMID: 38963167. doi:10.1111/clr.14323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。